The HTA core model: a novel method for producing and reporting health technology assessments.
about
HOSPITAL MANAGERS' NEED FOR INFORMATION ON HEALTH TECHNOLOGY INVESTMENTSSteps in Moving Evidence-Based Health Informatics from Theory to PracticeBurden of Disease Study and Priority Setting in Korea: an Ethical PerspectiveBridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.A model for assessment of telemedicine applications: mast.Mapping of health technology assessment in selected countries.Valorising and creating access to innovative medicines in the European union.Health economic modeling to assess short-term costs of maternal overweight, gestational diabetes, and related macrosomia - a pilot evaluation.Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.Systematic review of pharmacoeconomic studies of pharmacogenomic tests.Ethical issues of obesity surgery--a health technology assessment.Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.Evaluating Health Information Systems Using Ontologies.Toward a new information infrastructure in health technology assessment: communication, design, process, and results.EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE.The Model for Assessment of Telemedicine (MAST): A scoping review of empirical studies.AN INTEGRATED PERSPECTIVE ON THE ASSESSMENT OF TECHNOLOGIES: INTEGRATE-HTA.USING THE HEALTH TECHNOLOGY ASSESSMENT TOOLBOX TO FACILITATE PROCUREMENT: THE CASE OF SMART PUMPS IN A CANADIAN HOSPITAL.Validity of the Model for Assessment of Telemedicine: A Delphi study.Integrated HTA-FMEA/FMECA methodology for the evaluation of robotic system in urology and general surgery.Implementation of EUnetHTA core Model® in Lombardia: the VTS framework.Toward international good practices in health technology assessment.Participative Facility Planning for Obstetrical and Neonatal Care Processes: Beginning of Life ProcessTransferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries.INTEGRATE-HTA: THE PERSPECTIVE OF EUnetHTA.Toward a Method for Exposing and Elucidating Ethical Issues with Human Cognitive Enhancement Technologies.Standardized reporting for rapid relative effectiveness assessments of pharmaceuticals.Developing the HTA core model for the online environment.Impact assessment of Iran's health technology assessment programme.Evaluating facts and facting evaluations: On the fact-value relationship in HTA.The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicineTele-expertise for diagnosis of skin lesions is cost-effective in a prison setting: A retrospective cohort study of 450 patients
P2860
Q28072358-94C4C969-AD26-4E49-84BD-8DFF8347A79BQ28076287-E1ECED55-3DC9-4DF3-9749-3B89D74C1AA0Q28077560-A3110DD0-E2AB-432A-AB9D-4E98DC6E9781Q34086884-B39A8F4D-14DB-4639-9B96-B54B98CB5A19Q34276676-23576EA4-51BD-4269-B1D2-3DE33E34EB4AQ35056822-F1D9EC4E-A128-4C4D-A4DA-6D5FB6BEA6DAQ35303021-DB9A2748-AD9C-4450-9ABC-0B941E32F357Q35626034-50CC52F6-1774-408D-834A-9B90082402F0Q37661660-BAFA5A4F-AFB0-4061-9E3F-196F3506D60AQ37814401-E8558C6D-EA46-44C3-B9EC-9414CC467D3DQ37863542-A49F8D36-D89D-4A7D-A995-22BC7506C09BQ38369483-211DE769-1356-4E8E-8147-052120F489A3Q38391184-5367B9EF-0035-43AB-B88F-9B7436A6CF2FQ38432697-49352909-C350-49E0-B0BA-345233141428Q38546139-6AE4B863-7F9D-43BE-85B3-7E336D0FB8A9Q38649471-7E10AE48-1F93-4C81-95E5-2D1BB7A6FC05Q38653139-2258A108-8AF5-4894-81F2-BFBC30B1D3FCQ38675113-E31F0809-455C-46EE-8E31-03ADB2B1344FQ39063970-21A4E766-9753-4CC7-AEB5-0EBF26767B7AQ39585208-C777F6ED-5E48-4C04-8549-E93A59BD67E3Q43894085-373CF1AF-1A94-49E9-9375-CEEB8D9B6CD9Q44975327-8C5B8DC3-624B-408F-922D-74DF9D1D6C44Q46976157-DDB70ED6-1875-4BF3-8637-584289D893DEQ47893001-AD01A74D-3125-4F9C-B837-D6EF2E8B3346Q47964139-27997DC7-387A-4A68-B564-6961081FBCCBQ48176120-24BB1C3E-EE53-4ECC-A2F6-9BA73C73ED90Q48531778-CC894444-B539-4A78-B6F1-22E28D4529B0Q49150036-30C7A8FB-ABC6-46B9-9950-9415FA411547Q50301046-54645460-C8C8-486C-ADFA-D4747AD8AA68Q53832902-5E4579E9-3A93-4D37-9C09-304C5520A38CQ57899357-18A4DCF0-FE13-4515-9921-B27609CD5D79Q58701462-A6B15004-1B7C-4EC1-BBD7-3312C3310D63
P2860
The HTA core model: a novel method for producing and reporting health technology assessments.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The HTA core model: a novel me ...... health technology assessments.
@en
The HTA core model: a novel me ...... health technology assessments.
@nl
type
label
The HTA core model: a novel me ...... health technology assessments.
@en
The HTA core model: a novel me ...... health technology assessments.
@nl
prefLabel
The HTA core model: a novel me ...... health technology assessments.
@en
The HTA core model: a novel me ...... health technology assessments.
@nl
P2093
P2860
P1476
The HTA core model: a novel me ...... health technology assessments
@en
P2093
Antti Malmivaara
Björn Hofmann
European network for Health Technology Assessment (EUnetHTA)
Finn Børlum Kristensen
Heidi Anttila
Ilona Autti-Rämö
Inger Norderhaug
Iris Pasternack
Juha Koivisto
Kersti Meiesaar
P2860
P356
10.1017/S0266462309990638
P478
25 Suppl 2
P577
2009-12-01T00:00:00Z